These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 30809471)
41. The IMPACT study: a prospective evaluation of the effects of cyclosporine ophthalmic emulsion 0.05% on ocular surface staining and visual performance in patients with dry eye. Stonecipher KG; Torkildsen GL; Ousler GW; Morris S; Villanueva L; Hollander DA Clin Ophthalmol; 2016; 10():887-95. PubMed ID: 27257373 [TBL] [Abstract][Full Text] [Related]
42. Effects of topical cyclosporine a plus artificial tears versus artificial tears treatment on conjunctival goblet cell density in dysfunctional tear syndrome. Demiryay E; Yaylali V; Cetin EN; Yildirim C Eye Contact Lens; 2011 Sep; 37(5):312-5. PubMed ID: 21792057 [TBL] [Abstract][Full Text] [Related]
44. Effects of Menthol-Containing Artificial Tears on Tear Stimulation and Ocular Surface Integrity in Normal and Dry Eye Rat Models. Ahn S; Eom Y; Kang B; Park J; Lee HK; Kim HM; Song JS Curr Eye Res; 2018 May; 43(5):580-587. PubMed ID: 29419317 [TBL] [Abstract][Full Text] [Related]
45. The effect of punctal occlusion on tear production, tear clearance, and ocular surface sensation in normal subjects. Yen MT; Pflugfelder SC; Feuer WJ Am J Ophthalmol; 2001 Mar; 131(3):314-23. PubMed ID: 11239863 [TBL] [Abstract][Full Text] [Related]
46. Comparison of Topical Cyclosporine and Diquafosol Treatment in Dry Eye. Yang JM; Choi W; Kim N; Yoon KC Optom Vis Sci; 2015 Sep; 92(9):e296-302. PubMed ID: 26107023 [TBL] [Abstract][Full Text] [Related]
47. Direct visualization of aqueous tear secretion from lacrimal gland. Kim EC; Doh SH; Chung SY; Yoon SY; Kim MS; Chung SK; Shin MC; Hwang HS Acta Ophthalmol; 2017 Jun; 95(4):e314-e322. PubMed ID: 27879057 [TBL] [Abstract][Full Text] [Related]
48. An open-label, investigator-masked, crossover study of the ocular drying effects of two antihistamines, topical epinastine and systemic loratadine, in adult volunteers with seasonal allergic conjunctivitis. Ousler GW; Workman DA; Torkildsen GL Clin Ther; 2007 Apr; 29(4):611-6. PubMed ID: 17617284 [TBL] [Abstract][Full Text] [Related]
49. Additive Effect of preservative-free sodium hyaluronate 0.1% in treatment of dry eye syndrome with diquafosol 3% eye drops. Hwang HS; Sung YM; Lee WS; Kim EC Cornea; 2014 Sep; 33(9):935-41. PubMed ID: 25055152 [TBL] [Abstract][Full Text] [Related]
50. Two multicenter, randomized studies of the efficacy and safety of cyclosporine ophthalmic emulsion in moderate to severe dry eye disease. CsA Phase 3 Study Group. Sall K; Stevenson OD; Mundorf TK; Reis BL Ophthalmology; 2000 Apr; 107(4):631-9. PubMed ID: 10768324 [TBL] [Abstract][Full Text] [Related]
51. [Tear film and lacrimal excretion changes after lacrimal gland tumor removal]. Zhang YQ; Qian J; Yuan YF; Xue K; Guo J; Wang XN Zhonghua Yan Ke Za Zhi; 2013 Jan; 49(1):27-31. PubMed ID: 23601462 [TBL] [Abstract][Full Text] [Related]
52. Punctal occlusion for dry eye syndrome. Ervin AM; Law A; Pucker AD Cochrane Database Syst Rev; 2017 Jun; 6(6):CD006775. PubMed ID: 28649802 [TBL] [Abstract][Full Text] [Related]
53. Efficacy of topical cyclosporine A in the treatment of severe trachomatous dry eye. Guzey M; Karaman SK; Satici A; Ozardali I; Sezer S; Bozkurt O Clin Exp Ophthalmol; 2009 Aug; 37(6):541-9. PubMed ID: 19702702 [TBL] [Abstract][Full Text] [Related]
54. The effect of decreasing the dosage of cyclosporine A 0.05% on dry eye disease after 1 year of twice-daily therapy. Su MY; Perry HD; Barsam A; Perry AR; Donnenfeld ED; Wittpenn JR; D'Aversa G Cornea; 2011 Oct; 30(10):1098-104. PubMed ID: 21407074 [TBL] [Abstract][Full Text] [Related]
55. The Lacritin-Syndecan-1-Heparanase Axis in Dry Eye Disease. Dias-Teixeira K; Horton X; McKown R; Romano J; Laurie GW Adv Exp Med Biol; 2020; 1221():747-757. PubMed ID: 32274735 [TBL] [Abstract][Full Text] [Related]
56. A randomized double-masked study of 0.05% cyclosporine ophthalmic emulsion in the treatment of meibomian gland dysfunction. Prabhasawat P; Tesavibul N; Mahawong W Cornea; 2012 Dec; 31(12):1386-93. PubMed ID: 23135530 [TBL] [Abstract][Full Text] [Related]
57. The effects of 3% diquafosol sodium eye drop application on meibomian gland and ocular surface alterations in the Cu, Zn-superoxide dismutase-1 (Sod1) knockout mice. Ikeda K; Simsek C; Kojima T; Higa K; Kawashima M; Dogru M; Shimizu T; Tsubota K; Shimazaki J Graefes Arch Clin Exp Ophthalmol; 2018 Apr; 256(4):739-750. PubMed ID: 29484560 [TBL] [Abstract][Full Text] [Related]
58. Conserved regional 3' grouping of rare codons in the coding sequence of ocular prosecretory mitogen lacritin. McKown RL; Raab RW; Kachelries P; Caldwell S; Laurie GW Invest Ophthalmol Vis Sci; 2013 Mar; 54(3):1979-87. PubMed ID: 23422824 [TBL] [Abstract][Full Text] [Related]
59. The Efficiency of Cyclosporine A-Eluting Contact Lenses for the Treatment of Dry Eye. Choi JH; Li Y; Jin R; Shrestha T; Choi JS; Lee WJ; Moon MJ; Ju HT; Choi W; Yoon KC Curr Eye Res; 2019 May; 44(5):486-496. PubMed ID: 30580651 [TBL] [Abstract][Full Text] [Related]
60. Improvement of corneal barrier function by the P2Y(2) agonist INS365 in a rat dry eye model. Fujihara T; Murakami T; Fujita H; Nakamura M; Nakata K Invest Ophthalmol Vis Sci; 2001 Jan; 42(1):96-100. PubMed ID: 11133853 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]